Observational studyPloS one2018

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib.

Olivier Bouché et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.